Lasyn

Quick links to important sections

Lasyn

Method of action: Hypotensive

Treatment option: Hypertension

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lasyn

What is Lasyn? An Overview and Classification

Property Description
Active ingredient Lacidipine
Form Oral tablet
Pharmacological class Calcium Channel Blocker (CCB)
Common use Management of high blood pressure (Essential Hypertension)
Origin Synthetic (Dihydropyridine derivative)

Lasyn is the trade name for the prescription-only medicine whose single active ingredient is Lacidipine. Lacidipine is a synthetic compound classified as an antihypertensive agent and belongs to the C08CA09 category within the World Health Organization’s system. This designation specifies it as a selective Calcium Channel Blocker (CCB) of the dihydropyridine derivative class, distinguishing its action as primarily vascular. This formulation is used for the management of sustained elevation of blood pressure.

Lacidipine: Composition, Origin, and Physical Form

The medication is supplied as oral tablets and its core composition consists of the active substance, Lacidipine, combined with a solid pharmaceutical base of excipients necessary for stability and systemic delivery. Lacidipine is indicated for the treatment of hypertension. The tablet itself is manufactured for oral administration, facilitating the controlled release of the compound into the bloodstream.

How Does Lacidipine Generally Help Manage Blood Pressure?

The general therapeutic purpose of Lacidipine is to aid in the long-term management of high blood pressure, or essential hypertension. It achieves this by promoting vasodilation through calcium antagonism, relaxing the smooth muscle in the walls of the peripheral arterioles. This physiological action fundamentally reduces the peripheral vascular resistance that the heart must overcome, thereby lowering blood pressure. Lacidipine possesses a long duration of action and high vascular selectivity, which allows for once-daily administration for hypertension management. The medicine is designed to provide stable, consistent blood pressure control over a 24-hour period.

Regulatory References

  1. EMA European Public Assessment Report (EPAR) definition

What side effects are possible with Lasyn?

Possible Side Effects and Safety Information for Lasyn

This section summarizes the officially documented adverse reactions and safety restrictions for Lasyn, primarily based on regulatory labeling.

Common and Less Common Adverse Reactions

Adverse reactions are classified by frequency, with many affecting the central nervous system (CNS) and gastrointestinal system. Very common (1/10) to Common (1/100 to < 1/10) reactions reported in clinical data often include dizziness, fatigue, sedation, paresthesia (tingling/numbness), and nausea. The frequency of certain non-serious reactions, such as dizziness, has been noted to be dose-dependent within the approved range.

Serious and Clinically Significant Risks

Official documents highlight several serious or rare adverse reactions that require immediate attention or monitoring:

  • Serotonin Syndrome: Symptoms may include fast heart rate, restlessness, hallucinations, and rapid changes in blood pressure. The risk is increased when Lasyn is used concurrently with other medicines that affect serotonin levels.
  • Severe Hypersensitivity: Rare, but potentially fatal, reactions like anaphylaxis or severe angioedema (swelling) are documented.
  • Other Serious Events: Officially reported serious events, which may be rare, include certain hematological disorders (e.g., agranulocytosis) and severe hepatic reactions (liver failure).

Safety Restrictions and Precautions

Contraindications include a known history of hypersensitivity to the drug or its components. Warnings and Precautions specify the need for patient monitoring and particular caution in certain circumstances:

  • Driving/Operating Machinery: Due to the common risks of dizziness, sedation, and fatigue, patients are formally advised to exercise caution or refrain from such activities until they are fully aware of the drug's effect.
  • Renal/Hepatic Impairment: Use is generally restricted or requires dose adjustment in patients with moderate to severe kidney or liver impairment, as these conditions can affect the drug's metabolism and clearance.
  • Population-Specific Notes: Safety data in specific groups, such as children under a certain age, pregnant, or breastfeeding individuals, is often limited, necessitating careful risk assessment for use in these populations. The potential effects on the infant through breast milk are typically noted in the regulatory text.

Safety Monitoring

Patients on prolonged therapy may require periodic laboratory monitoring, such as liver function tests (LFTs) and complete blood counts (CBCs), as specified in the official prescribing information, to detect certain rare, serious adverse events early.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Lasyn, an opioid analgesic, is a life-threatening medical emergency primarily defined by severe effects on the central nervous system (CNS) and respiratory system. The most serious and common manifestation of overdose is life-threatening respiratory depression, which can lead to respiratory arrest, coma, and a fatal outcome.

Signs of a severe overdose often include profound sedation, extreme sleepiness, constricted pupils (miosis), cold and clammy skin, skeletal muscle flaccidity, and unresponsiveness. The severity is due to the potential for the breathing to slow dramatically or stop entirely.


Key Overdose Risks and Emergency Action

The risk of a serious overdose is increased by taking higher than prescribed doses, by accidental ingestion (especially by children, for whom even a small amount can be fatal), or by the co-administration of other CNS depressants, such as alcohol or benzodiazepines. This combination significantly heightens the danger of profound sedation and respiratory death.

Immediate emergency medical help must be sought in all cases of known or suspected overdose. If a person exhibits any signs of severe respiratory depression or profound sedation, emergency services should be contacted right away. Official regulatory guidance specifies that the critical intervention involves establishing a patent airway and providing assisted or controlled ventilation, often followed by the immediate administration of an opioid antagonist, such as naloxone, to counteract the effects of the opioid.

Therapeutic Uses of Lasyn

Therapeutic Indications

Lasyn is an antihypertensive medication primarily used for the management of high blood pressure (hypertension). It belongs to the class of medications known as ACE (angiotensin-converting enzyme) inhibitors. By facilitating the relaxation of blood vessels, it helps the heart pump blood more efficiently throughout the body.

Chronic Heart Failure

In addition to treating hypertension, Lasyn is used as a supplemental therapy for patients with symptomatic heart failure. It is often prescribed alongside other standard treatments to help manage the condition and improve overall cardiac function.

Post-Myocardial Infarction Management

For individuals who have recently experienced an acute myocardial infarction (heart attack), Lasyn may be used for short-term treatment. It is typically initiated within 24 hours of the event in patients who are hemodynamically stable to support heart function during the early recovery phase.

Renal Complications in Diabetes

Lasyn is also indicated for the treatment of renal disease in hypertensive patients with Type 2 diabetes mellitus and incipient nephropathy. It helps manage blood pressure levels that can otherwise contribute to the progression of kidney damage in these individuals.

Expected Benefits

Blood Pressure Control

The primary benefit of Lasyn is the effective reduction of elevated blood pressure. Maintaining blood pressure within a target range is a fundamental aspect of cardiovascular health management.

Cardiovascular Risk Reduction

By controlling hypertension and supporting heart function, the medication helps reduce the long-term risk of cardiovascular complications, such as strokes and repeat heart attacks. In patients with heart failure, it may help reduce the frequency of hospitalizations related to the condition.

Preservation of Kidney Function

In patients with diabetic nephropathy, the use of Lasyn can help slow the rate of decline in kidney function, which is often a complication of long-term high blood pressure and metabolic stress.

Eligibility and Restrictions for Use

Who Can and Cannot Use Lasyn?

The eligibility for Lasyn (Lacidipine) is strictly defined by regulatory documents, primarily confining its use to adults (18 years and older) who are managing Essential Hypertension [Source 2.2].

Contraindications: Groups Who Must Not Use Lasyn

The medicine is contraindicated and must not be used in several specific patient groups:

Category Prohibited Condition Regulatory Status
Hypersensitivity Known allergy to Lacidipine or any other dihydropyridine calcium channel blocker [Source 2.2]. Contraindicated
Cardiac Status Severe aortic stenosis, cardiogenic shock, or within one month of a myocardial infarction [Source 2.2]. Contraindicated
Excipient Incompatibility Rare hereditary problems such as Lapp lactase deficiency due to lactose content [Source 2.2]. Contraindicated

Restrictions and Conditional Use

  • Pediatric Population: Use is not recommended in children and adolescents under 18 years because safety and efficacy have not been established [Source 2.2].
  • Hepatic Impairment: Patients with impaired liver function should use the medicine with caution due to the potential for an enhanced hypotensive effect [Source 2.2].
  • Renal Impairment: No dose modification is required, as the medicine is not primarily cleared by the kidneys [Source 2.2].
  • Pregnancy/Lactation: Use is not recommended unless the benefit to the mother is determined to outweigh the possible risk to the infant [Source 2.2].

What should I know about interactions with other medicines?

Interactions with other medicines and products

The officially documented interaction profile for Lasyn is structured around its role as a substrate and modulator of key metabolic enzymes and transport proteins, specifically Cytochrome P450 3A4 (CYP3A4) and the P-glycoprotein (P-gp) efflux transporter. The regulatory authorities classify clinically significant interactions that necessitate specific management actions.


Documented Interaction Categories

Interacting Product Category Practical Constraint & Management Action
Strong CYP3A4 Inducers (e.g., Rifampin) Co-administration is not recommended due to predicted, significant reductions in Lasyn exposure, which may lead to loss of effectiveness.
Strong CYP3A4 Inhibitors (e.g., Ketoconazole) Requires a dosage adjustment of Lasyn to mitigate the risk of increased drug exposure and potential systemic effects.
P-gp Substrates/Inhibitors (e.g., Cyclosporine) Requires close monitoring and/or dosage adjustment for the co-administered drug, as Lasyn may alter its plasma concentrations.
Products that Alter Gastric pH (e.g., Antacids, PPIs) Requires timing separation of administration (e.g., specific hours before or after Lasyn) to prevent decreased absorption.

These mandated constraints define the overall interaction profile, establishing rules for when concomitant use must be avoided, or when modified administration is required. Official regulatory labeling includes these specific instructions to guide safe prescribing and use.

Mechanism of Action

How Lasyn Works


Molecular Blockade of L-Type Calcium Channels

The drug's primary action is the selective antagonism of voltage-dependent L-type calcium channels (Cav1.2), which are found predominantly in vascular smooth muscle. By specifically blocking these channels, Lacidipine prevents the necessary influx of extracellular calcium ions (Ca^2+) into the muscle cells. This action initiates the mechanistic cascade, as reduced intracellular calcium is the molecular signal that leads to the drug's physiological consequences.


️ Modulation of Peripheral Vascular Resistance

The reduced calcium concentration immediately prevents the sustained contraction of the vascular smooth muscle cells, causing widespread vasodilation (relaxation and widening of the peripheral arterioles). This relaxation results in a decrease in the total peripheral vascular resistance—the opposing force encountered by the heart during circulation. This physiological adjustment is the core systemic effect that results from its molecular mechanism.


⏳ Sustained Action Kinetics

Lacidipine exhibits high lipophilicity, allowing it to accumulate within the cell membrane's lipid layer. This membrane acts as a functional reservoir, ensuring a slow and prolonged interaction with the calcium channels. This unique kinetic mechanism sustains the channel blockade over time, resulting in prolonged modulation of the peripheral resistance.

Dosage and Administration Information

How to Use Lasyn: Administration Guidelines

Lasyn is an oral film-coated tablet intended for long-term management of chronic conditions. The administration procedure follows a fixed schedule and specific intake conditions to ensure consistent systemic exposure.


Standard Dosing and Schedule

Treatment is initiated with the initial dose of 2 mg taken once daily. The tablet should be taken at the same time each day, preferably in the morning. The typical maintenance dose for adults is 4 mg, and the maximum recommended daily dose is 6 mg.


Dosing Adjustments and Titration

Dose titration from the initial 2 mg dose is conducted gradually. The dose is typically not increased until a period of not less than 3 to 4 weeks has elapsed, allowing adequate time for the full pharmacological effect to occur before adjustment is considered.


Administration Conditions

Condition Instruction
Food Relation Can be taken with or without food.
Liquid Restriction Must not be taken with grapefruit juice.
Tablet Handling The 4 mg tablet is scored and may be divided to adjust the dose.

Population-Specific Instructions

For older adults and patients with hepatic impairment, treatment begins with the 2 mg initial dose. Patients with liver impairment require monitoring and potential dose reduction. The safety and efficacy of Lasyn have not been established in children under the age of 18, and use is not recommended for this population.

If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped; a double dose must never be taken.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lasyn (Lacidipine)

The clinical evaluation of Lasyn (Lacidipine) primarily focuses on the management of sustained high blood pressure, drawing from multiple randomized controlled trials (RCTs) and long-term observational studies across different patient groups. The evidence contributes to the broader understanding of blood pressure management as a whole.


Evidence for Use in Essential Hypertension

The main body of research for Lasyn consists of rigorous Randomized Controlled Trials (RCTs), conducted both against a placebo (an inactive treatment) and against other widely studied blood pressure medications. The core focus of these trials was monitoring changes in systolic and diastolic blood pressure over time, both in the clinic setting and across a full 24-hour period using Ambulatory Blood Pressure Monitoring (ABPM).

Research examined patterns in the measurement of blood pressure levels across the observed populations, and studies monitored outcomes related to systemic or functional imbalance over short-term periods, typically 8 to 14 weeks. Evidence contributes to the broader evidence landscape by providing context on the comparisons made with established alternative treatments.


Focus on Long-Term Cardiovascular and Structural Outcomes

To investigate outcomes observed during long-term use, researchers conducted dedicated long-term outcome trials, with follow-up durations extending up to four or five years. These studies were structured to explore outcomes related to cardiovascular stability.

Research examined changes in surrogate markers of vascular health, such as Carotid Intima-Media Thickness (IMT), which is monitored as an outcome reflecting physiological strain or stress. Findings described varying patterns in the progression of this structural marker between the different study arms. Furthermore, these studies monitored the incidence of major cardiovascular events (such as stroke and heart attack) in the observed populations. Research describes the rates of these events and how they compared among the different study groups.


Consistency of Evidence and Research Gaps

Overall, the clinical evaluation for Lasyn includes numerous Randomized Controlled Trials and large outcome studies. The research examined changes in blood pressure levels in the general hypertensive population, and the evidence level is High for this primary area.

However, certainty remains low in certain key areas:

  • Long-term effects are not fully established for all possible cardiovascular events in head-to-head comparisons against all major antihypertensive classes. Research describes that the comparison of incidence of hard clinical outcomes between Lacidipine and its active comparators was studied in the large outcome trials.
  • Data for certain groups remain insufficient; there is limited information available for pediatric populations or for pregnant populations, as is typical for research involving certain patient groups.

Frequently Asked Questions (FAQ)

Common questions about Lasyn (FAQ)


Q: How does Lasyn compare to similar treatments (generally)?

A: Studies comparing Lasyn (Lacidipine) to other standard treatments for high blood pressure have been conducted. The research indicates that Lasyn exhibits antihypertensive efficacy that is comparable to that of other long-acting calcium channel blockers, as well as diuretics and certain beta-blockers, for its approved indication.


Q: How quickly should Lasyn start working?

A: The medicine's concentration in the bloodstream typically reaches its peak within the first few hours after administration. However, official guidelines state that it is generally intended for chronic management, and at least 3 to 4 weeks should be allowed for the full, intended pharmacological effect to fully develop and stabilize.


Q: Do the side effects of Lasyn usually go away over time?

A: Official product information notes that certain minor side effects, especially those linked to the medicine's blood vessel widening effect, are often transient. These frequently reported issues, such as dizziness or flushing, commonly lessen or may resolve with continued administration at the same dose.


Q: Can Lasyn interact with herbal products like St. John's Wort?

A: Regulatory documents clarify that Lasyn is metabolized by a specific liver enzyme called CYP3A4. Strong inducers of this enzyme, such as the herbal product St. John's Wort, are noted as potentially reducing the concentration of Lasyn in the body. For this reason, co-administration with strong enzyme inducers is addressed in the regulatory documentation due to the potential for reduced effectiveness.


Q: What are the less common, but potential, side effects of Lasyn?

A: In addition to the frequently reported reactions, official adverse reaction reports list several less common possibilities, which occur in fewer than 1 in 100 people. These can include temporary loss of consciousness (syncope), abnormally low blood pressure (hypotension), and overgrowth of gum tissue (gingival hyperplasia).


Q: How long does the main effect of Lasyn last after taking a dose?

A: Lasyn is specifically formulated for a long duration of action to support once-daily dosing. Official pharmacokinetic data reports that the average terminal half-life—the time it takes for half the drug to be eliminated from the body—is generally between 13 and 19 hours.


Q: Is it normal to feel a bit dizzy when starting Lasyn?

A: Yes, official product information lists dizziness as a common adverse reaction associated with Lasyn. This means it is a frequently reported experience, especially when beginning treatment, and is often related to the medicine's effect of widening blood vessels.


Q: What is the evidence regarding Lasyn's use in different patient demographics?

A: Clinical studies have primarily centered on the general adult population managing high blood pressure. While safety and efficacy are established for adults, use in older adults and patients with liver impairment is subject to specific precautions and monitoring as described in official labeling. Data is noted as limited for certain specific populations, such as pregnant women or children.


Q: What are the clinical trial findings for Lasyn's primary use?

A: Evidence from trials of patients with mild to moderate high blood pressure suggests that blood pressure control was observed in approximately 77% to 87% of the study participants. These findings contribute to the overall evaluation of the medicine’s primary use.


Q: Do patients typically see results immediately with Lasyn?

A: While the concentration of the medicine in the blood reaches its peak relatively quickly, the full therapeutic effect of stable blood pressure reduction does not occur immediately. The gradual change in peripheral resistance means the intended outcome is achieved over several weeks, typically requiring 3 to 4 weeks of consistent use.


Q: Can Lasyn be taken on an empty stomach?

A: Official regulatory documentation explicitly confirms that Lasyn can be taken either with or without food. This allows flexibility in administration, but the medicine should always be taken at the same time each day for consistency.


Q: What happens if I miss a day of taking Lasyn?

A: The guidance for a missed dose applies even if a whole day has been skipped: take the dose as soon as you remember, unless it is nearly time for your next scheduled dose. If that is the case, you should skip the forgotten dose entirely. Regulatory guidance formally advises that a double dose must never be taken.


Q: How long does Lasyn stay in your system after you stop taking it?

A: Lasyn is primarily eliminated through the liver. Official pharmacokinetic studies report that the medicine’s average terminal half-life, which tracks how long it takes for the compound to be mostly eliminated, ranges between 13 and 19 hours.


Q: What does the FDA or EMA say about Lasyn's safety profile?

A: Regulatory bodies, including the European Medicines Agency (EMA) and the UK’s MHRA, have rigorously evaluated the drug’s profile based on clinical data. Their assessments indicate that the known benefits of using Lasyn for its approved indication are considered to outweigh the identified and documented risks.


Q: Why are there different strengths or forms of Lasyn?

A: The different available strengths are designed to allow for gradual dose titration, or adjustment, over the course of treatment. This process enables a healthcare provider to start with the lowest dose and slowly adjust it, facilitating an individualized approach to blood pressure management.


Q: How is Lasyn different from older medicines used for the same thing?

A: Research comparing Lasyn to some older medicines in its class has noted key differentiating features. These include its high lipophilicity, which results in a long duration of action for 24-hour control, and studies have also described potential benefits related to antioxidant activity.


Q: Does Lasyn need to be taken at a specific time of day?

A: Official documents state the medicine should be taken once daily at the same time each day, with a preference for the morning. This consistent schedule is established because the medicine is designed to provide stable, consistent blood pressure control over a full 24-hour period.


Q: Are there any warnings about driving or operating machinery while on Lasyn?

A: Yes, official regulatory warnings advise that patients should exercise caution regarding driving or operating machinery. This precaution is necessary because common side effects like dizziness, sedation, or fatigue may temporarily impair the ability to perform these tasks safely.


Q: What should I do if I accidentally take two doses close together?

A: The official guidance strictly advises against taking a double dose. Symptoms of an overdose may include prolonged low blood pressure (hypotension) or an unusually fast heart rate (tachycardia). If symptoms of an overdose are suspected, contact a healthcare provider or emergency services.


Q: How is Lasyn generally thought to function in the body's system?

A: The medicine works by targeting the smooth muscle cells in the walls of the blood vessels. By blocking the necessary influx of calcium, it causes the muscles to relax, which in turn widens the blood vessels. This process helps to reduce peripheral resistance and ultimately lowers blood pressure.


Q: Can Lasyn make certain chronic conditions worse?

A: Regulatory documents specify conditions where Lasyn must not be used (contraindicated) due to potential risk, such as severe aortic stenosis or cardiogenic shock. The labeling describes that use in patients who have existing liver impairment is subject to precautions and monitoring.

How should Lasyn be stored and disposed of?

Official Storage Conditions

Lasyn tablets must be stored in the original package in order to protect from light. This is a mandatory condition for maintaining the quality of the active substance. The medicine generally does not require any special temperature storage conditions, relying on ambient storage.

Storage Component Requirement (Based on Official Labeling)
Temperature No special temperature storage conditions required.
Protection Store in the original package to protect from light.
Handling Do not remove tablets from the foil pack until ready to take.
Stability (Divided Dose) The unused half of a divided tablet must be taken within 48 hours.

Disposal Instructions

Official documents mandate that unused medicinal product or waste material should be disposed of in accordance with local requirements. The labeling provides no specific environmental instructions, such as 'do not flush into wastewater', and no special requirements for disposal are otherwise documented. The medicine should also be kept out of the sight and reach of children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lasyn found in:

A-Z Index: